← Open Payments lookup

GEOFFREY JEYASINGHAM: Open Payments

NPI 1124517404 · JEFFERSONVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,905 in 145 payments from 14 companies in 2025. Trend: 2023 $1,204 · 2024 $1,775 · 2025 $2,905

Food & beverage: $2,712Education: $193
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.36$860
Alkermes, Inc.18$512
Otsuka America Pharmaceutical, Inc.26$404
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)16$230
ABBVIE INC.14$188
Lundbeck LLC10$144
Janssen Pharmaceuticals, Inc5$125
Axsome Therapeutics, Inc.6$118
E.R. Squibb & Sons, L.L.C.3$82
Neurocrine BioSciences, Inc.3$67

Products named: UZEDY, ARISTADA, ABILIFY ASIMTUFII, REXULTI, CAPLYTA, VRAYLAR, LYBALVI, Auvelity.

Industry payments across IN — which companies pay providers there.